Document Detail


Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia.
MedLine Citation:
PMID:  19630844     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine whether a 24% increase in patient co-payments in January 2005 and two related co-payment changes for medicines subsidised under the Australian Pharmaceutical Benefits Scheme (PBS) were associated with changes in dispensings in Western Australia (WA). METHOD: We analysed aggregate monthly prescription counts and defined daily dose per 1,000 population per day (DDD/1,000/day) for atypical antipsychotics, combination asthma medicines, HmgCoA reductase inhibitors (statins) and proton-pump inhibitors (PPIs). Trends pre and post the co-payment increase in January 2005 were compared. RESULTS: In three of the four categories examined, prescription counts were significantly lower following the increase in co-payment thresholds. Compared with dispensings prior to the co-payment increase, prescriptions fell by 8% for combination asthma medicines (p<0.001), 9% for PPIs (p<0.001) and 5% for statins (p<0.001). Following the rise in co-payments, DDD/1,000/day decreased for all four categories. Decreases in dispensings to concessional beneficiaries were between 4% and 5% larger than for general beneficiary patients. CONCLUSIONS AND IMPLICATIONS: The reduction in the both prescription counts and DDD/1,000/day observed for combination asthma medicines, PPIs and statins, which all remained above co-payment thresholds, suggests the increase in PBS co-payments has affected utilisation of these subsidised medicines. The results indicate that increases in patient contributions particularly impact on concessional patients' ability to afford prescription medicines.
Authors:
Anna Hynd; Elizabeth E Roughead; David B Preen; John Glover; Max Bulsara; James Semmens
Related Documents :
19998574 - Government regulation of pricing and reimbursement of prescription medicines: results o...
21221284 - Appraisal of meconium at delivery: a look at intervention strategies.
25404224 - Taxonomy and compositional analysis of two new for science medicinal mushroom taxa from...
19768514 - Joseph c. risser sr., 1892-1982.
8792174 - Towards quality in complementary health care: is the german "heilpraktiker" a model for...
18260554 - Veterinary advice for entrepreneurial dutch dairy farmers: from curative practice to co...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Australian and New Zealand journal of public health     Volume:  33     ISSN:  1326-0200     ISO Abbreviation:  Aust N Z J Public Health     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-07-27     Completed Date:  2009-09-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9611095     Medline TA:  Aust N Z J Public Health     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  246-52     Citation Subset:  IM    
Affiliation:
School of Population Health, The University of Western Australia, New South Wales, Australia. anna.hynd@uwa.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost Sharing / economics*,  trends
Databases as Topic
Financing, Government
Humans
Insurance, Pharmaceutical Services / economics*
National Health Programs / economics
Pharmaceutical Preparations / economics*
Western Australia
Chemical
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A break-even analysis of a community rehabilitation falls prevention service.
Next Document:  Using a research framework to identify knowledge gaps in research on food marketing to children in A...